Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Azin1/tecr reprograms fatty acid metabolism to drive Acute Myeloid Leukemia progression

View Full Paper
Ask AI
Bookmark
Share

Authors

FWFengjiao WangYWYifei WangSYShangda Yang

Discussion

Loading...

Member takes

Overview

Metabolic reprogramming promotes leukemia stem cell function in acute myeloid leukemia, suggesting new intervention strategies.

Key Points

  • Leukemia stem cell function is impaired by Azin1 deletion, leading to prolonged survival in a mouse model.
  • 5-fluorouracil challenge revealed metabolic vulnerabilities influenced by fatty acid metabolism in acute myeloid leukemia.
  • Trans-2-enoyl-CoA reductase stability is regulated by Azin1, indicating its role in lipid metabolic dysregulation.
  • Future strategies may target Azin1 to exploit metabolic reprogramming for acute myeloid leukemia therapies.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/69362f604fa91c937236dcb5https://doi.org/10.1182/blood-2025-1464
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting METTL3 disrupts oncogenic transcriptional programs and activates immune and apoptotic pathways in Acute Myeloid Leukemia2025
  2. 2Inhibition of CPT1A reverses AML1-ETO-induced differentiation blockage by activating BCL-2/MYC signaling and metabolic reprogramming2025
  3. 3SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia2025 · 4 citations
  4. 4ENO1 promotes Acute Myeloid Leukemia progression through SCD1-mediated lipid metabolism reprogramming2025
  5. 5Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia2025 · 1 citations